SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision

🎯 Drug Targets

Browse 3 drug targets with druggability analysis, composite scores, and clinical context

3
Targets
0
High Druggability
0.60
Avg Score
15
Target Classes
Druggability Distribution
High: 0Medium: 3Low: 0Unknown: 0
Avg druggability score: 0.471
Clinical Pipeline
Approved: 2Phase III: 0Phase II: 1Phase I: 0Preclinical: 0
Total compounds: 9 · Approved: 3
Class All Classes Enzyme (35) Signaling Protein (25) Structural Protein (17) Protein (16) Gpcr (13) Ion Channel (12) Receptor (11) Transcription Factor (11) Ligand (10) Epigenetic Regulator (8) Transporter (8) Kinase (7) Other (4) Protease (4) Chaperone (4)
Druggability All Druggability Low (97) Medium (56) Undruggable (19) High (10) other (3)
Sort Score Druggability Gene A-Z Market Price
Filtered by: class=ligand, druggability=Medium — 3 results
IL1B Interleukin-1 beta Approved
Ligand Medium Druggability
Score
0.65
Drug.
0.49
Safety
0.60
Drugs
2
Hyps
3
Papers
0
IL-1 receptor antagonist or neutralizing monoclonal antibody
APOE Apolipoprotein E Phase II
Ligand Medium Druggability
Score
0.62
Drug.
0.47
Safety
0.40
Drugs
4
Hyps
50
Papers
31
Protein-protein interaction modulator or lipid metabolism enhancer
HCRT Hypocretin/Orexin Approved
Ligand Medium Druggability
Score
0.53
Drug.
0.46
Safety
0.60
Drugs
3
Hyps
3
Papers
31
Peptide hormone replacement or stabilization approaches
Exchange | Dashboard